DE69611291D1 - Gel mit erhöhtem sauerstoffgehalt - Google Patents

Gel mit erhöhtem sauerstoffgehalt

Info

Publication number
DE69611291D1
DE69611291D1 DE69611291T DE69611291T DE69611291D1 DE 69611291 D1 DE69611291 D1 DE 69611291D1 DE 69611291 T DE69611291 T DE 69611291T DE 69611291 T DE69611291 T DE 69611291T DE 69611291 D1 DE69611291 D1 DE 69611291D1
Authority
DE
Germany
Prior art keywords
gelatin
oxygen content
solvent
oxygen
increased oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69611291T
Other languages
English (en)
Other versions
DE69611291T2 (de
Inventor
Peter Kolta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANDANYI JOZSEF
Original Assignee
LANDANYI JOZSEF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANDANYI JOZSEF filed Critical LANDANYI JOZSEF
Publication of DE69611291D1 publication Critical patent/DE69611291D1/de
Application granted granted Critical
Publication of DE69611291T2 publication Critical patent/DE69611291T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
DE69611291T 1995-04-26 1996-04-26 Gel mit erhöhtem sauerstoffgehalt Expired - Lifetime DE69611291T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9501193A HU213450B (en) 1995-04-26 1995-04-26 Gel contains gelatin and process for producing it
PCT/HU1996/000022 WO1996033695A2 (en) 1995-04-26 1996-04-26 Gel with increased oxygen content

Publications (2)

Publication Number Publication Date
DE69611291D1 true DE69611291D1 (de) 2001-01-25
DE69611291T2 DE69611291T2 (de) 2001-08-09

Family

ID=10986758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69611291T Expired - Lifetime DE69611291T2 (de) 1995-04-26 1996-04-26 Gel mit erhöhtem sauerstoffgehalt

Country Status (7)

Country Link
US (1) US6139876A (de)
EP (1) EP0822807B1 (de)
AT (1) ATE198147T1 (de)
AU (1) AU5657796A (de)
DE (1) DE69611291T2 (de)
HU (1) HU213450B (de)
WO (1) WO1996033695A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
CA2436427A1 (en) * 2001-02-01 2002-08-08 Hydron Technologies, Inc. Compositions and method of tissue superoxygenation
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
US7648719B2 (en) * 2001-12-04 2010-01-19 Peter Kolta Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material
CA2468856C (en) 2001-12-05 2011-07-26 Osao Sumita Method and apparatus for producing negative and positive oxidative reductive potential (orp) water
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050244354A1 (en) * 2004-04-30 2005-11-03 Sam Speron Oxygenated personal care products
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
RU2406509C2 (ru) * 2004-10-07 2010-12-20 Нген Фармасьютикалз Н.В. Композиция для лечения ран и ожогов
WO2006102681A2 (en) 2005-03-23 2006-09-28 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
US9498548B2 (en) 2005-05-02 2016-11-22 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
AU2007205861B2 (en) 2006-01-20 2013-05-09 Oculus Innovative Sciences, Inc. Methods of treating or preventing sinusitis with oxidative reductive potential water solution
US8808754B2 (en) 2006-06-29 2014-08-19 Systagenix Wound Management (Us), Inc. Methods for the treatment of wounds
DE102007028028A1 (de) 2007-06-14 2008-12-18 Beiersdorf Ag Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
US8992516B2 (en) 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
US8202272B2 (en) 2007-07-19 2012-06-19 Avedro, Inc. Eye therapy system
EP2227197A4 (de) 2007-12-05 2011-06-22 Avedro Inc Augentherapiesystem
US8348935B2 (en) 2008-01-23 2013-01-08 Avedro, Inc. System and method for reshaping an eye feature
US8469952B2 (en) * 2008-01-23 2013-06-25 Avedro, Inc. System and method for positioning an eye therapy device
US8409189B2 (en) * 2008-01-23 2013-04-02 Avedro, Inc. System and method for reshaping an eye feature
EP2346457A4 (de) * 2008-09-19 2012-03-07 Avedro Inc Augentherapiesystem
WO2010039854A1 (en) * 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
WO2010039979A1 (en) * 2008-10-01 2010-04-08 Avedro, Inc. Eye therapy system
WO2010056848A1 (en) * 2008-11-11 2010-05-20 Avedro, Inc. Eye therapy system
JP2012522602A (ja) * 2009-04-02 2012-09-27 アヴェドロ・インコーポレーテッド 眼治療システム
WO2010115121A1 (en) 2009-04-02 2010-10-07 Avedro, Inc. Eye therapy system
BRPI1011886B1 (pt) 2009-06-15 2022-05-03 Invekra, S.A.P.I De C.V Solução antimicrobiana de baixo ph
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
WO2011053768A2 (en) * 2009-10-30 2011-05-05 Avedro, Inc. System and method for stabilizing corneal tissue after treatment
JP6377906B2 (ja) 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼治療を適用およびモニターするためのシステム
KR101936686B1 (ko) * 2010-11-24 2019-01-11 (주)아모레퍼시픽 미세 버블을 함유하는 피부 외용제 조성물
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
JP6122845B2 (ja) 2011-06-02 2017-04-26 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 時間ベースの光活性剤の送達又は光活性マーカの存在をモニターするシステム及び方法
JP6271541B2 (ja) 2012-07-16 2018-01-31 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． パルスの光による角膜の架橋のためのシステム及び方法
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
EP3212140B1 (de) 2014-10-27 2021-12-01 Avedro, Inc. Systeme zur vernetzung von behandlungen trockener augen
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3285704B1 (de) 2015-04-24 2020-11-18 Avedro Inc. Systeme zur lichtaktivierung eines an einem auge applizierten lichtsensibilisators
WO2016191342A1 (en) 2015-05-22 2016-12-01 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
CN108025011A (zh) 2015-07-21 2018-05-11 艾维德洛公司 用光敏剂治疗眼睛的系统和方法
WO2019173762A1 (en) 2018-03-08 2019-09-12 Avedro, Inc. Micro-devices for treatment of an eye
JP2022544110A (ja) 2019-08-06 2022-10-17 アヴェドロ・インコーポレーテッド 角膜の架橋治療のための光活性化システム及び方法
CA3176016A1 (en) * 2020-04-24 2021-10-28 Michael Beattie Uses of super-oxygenated water and gel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011950A (en) * 1959-05-19 1961-12-05 Colgate Palmolive Co Liquid composition containing discrete gaseous bodies
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3639575A (en) * 1968-06-19 1972-02-01 Basf Wyandotte Corp Silver ion gel compositions and method of using the same
EP0505478B1 (de) * 1989-12-14 1996-11-27 Elof Eriksson Behandlungssystem für wunden und andere fehler
US5152757A (en) * 1989-12-14 1992-10-06 Brigham And Women's Hospital System for diagnosis and treatment of wounds
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
DE4236607A1 (de) * 1992-10-29 1994-05-05 Lancaster Group Ag Fluorcarbonemulsion enthaltende, als Kosmetika oder Dermatika einsetzbare Zubereitungen
DE4405627A1 (de) * 1994-02-22 1995-08-24 Hoechst Ag Fluorkohlenwasserstoffe enthaltende Ölemulsionen
HU217450B (hu) * 1994-04-27 2000-01-28 Life International Products, Inc. Eljárás és berendezés oxigénnel dúsított italok előállítására

Also Published As

Publication number Publication date
WO1996033695A3 (en) 1996-11-28
AU5657796A (en) 1996-11-18
WO1996033695A2 (en) 1996-10-31
US6139876A (en) 2000-10-31
EP0822807B1 (de) 2000-12-20
ATE198147T1 (de) 2001-01-15
HUT74315A (en) 1996-12-30
EP0822807A2 (de) 1998-02-11
HU213450B (en) 1997-06-30
HU9501193D0 (en) 1995-06-28
DE69611291T2 (de) 2001-08-09

Similar Documents

Publication Publication Date Title
DE69611291T2 (de) Gel mit erhöhtem sauerstoffgehalt
KR880009639A (ko) 서방성 매트릭스 제형
ES2107022T3 (es) Composicion de polimero, composicion de un material de absorcion, su fabricacion y su empleo.
GR940100370A (el) Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
KR890004689A (ko) 니트로글리세린 스프레이
DE69427908D1 (de) Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
BR9910251A (pt) Estimulação hematopoiética
TNSN94035A1 (fr) Composition veterinaire
ES2054069T3 (es) Composicion cosmetica o farmaceutica que contiene microesferas de polimeros o de cuerpos grasos cargados de al menos un producto activo.
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ES2170179T3 (es) Agente analgesico y su utilizacion.
DE60029300D1 (de) Zusammensetzungen, die reduziertes malto-oligosaccharid als konservierungsmittel enthalten
BR9916304A (pt) Goma de mascar contendo agentes ativos demedicamentos
DK0977539T3 (da) Konserveringsmiddelsammensætning omfattende iodpropynylbutylcarbamat og phenoxyethanol
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
DK1489D0 (da) Medicinsk hudelektrode
GR3036822T3 (en) Eye lotion in particular for dry eye treatment
SU1459215A1 (ru) Состав полимерной диффузионной матрицы для трансдермального введения лекарственных веществ
CN1243713A (zh) 一种鹿血保鲜的方法
KR927002996A (ko) 발모촉진용 조성물
RU95101881A (ru) Способ консервации хряща
ES8800609A1 (es) Procedimiento de obtencion de un parche para la administracion transdermica de agentes farmacologicamente activos.
RU95105084A (ru) Гепатопротекторное средство природного происхождения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition